Illumina, Inc. (ILMN)
Pre-market:
| Previous close | 213.84 |
| Open | 222.12 |
| Bid | 221.88 x 800 |
| Ask | 226.99 x 1100 |
| Day's range | 219.34 - 227.61 |
| 52-week range | 173.45 - 371.16 |
| Volume | |
| Avg. volume | 1,348,538 |
| Market cap | 34.925B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 51.88 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
DNA Data Storage Alliance Announces Board Appointments
SAN DIEGO, March 29, 2023--The DNA Data Storage Alliance, a SNIA Technology Affiliate, formed in 2020 by Illumina, Inc. (NASDAQ: ILMN), Microsoft (Nasdaq: MSFT), Twist Bioscience Corporation (NASDAQ: TWST) and Western Digital (NASDAQ: WDC) to create and promote an interoperable storage ecosystem based on DNA as a data storage medium, today announced the appointments of CATALOG Technologies and Quantum Corporation to the governing board of the Alliance. David Turek will represent CATALOG and Don
- PR Newswire
Illumina launches new software to enable tertiary analysis for oncology applications, and soon rare disease
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing (NGS) data.
- PR Newswire
Illumina Issues Statement in Response to Carl Icahn's Letter
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023:
